Top Markets
Coin of the day
HeraMED Limited HeraMED Limited

HeraMED Limited

HMD
Classement en actions #28091
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Prix de l'action
$0.02468497
Capitalisation boursière
$28.60M
Changement (1 jour)
-5.41%
Changement (1 an)
53.47%
Pays
AU
Échange HeraMED Limited (HMD)

Catégorie

Ratio P/B pour HeraMED Limited (HMD)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de HeraMED Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour HeraMED Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US